Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumors.

@article{Briganti2001OctreoscanSE,
  title={Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumors.},
  author={Vittorio Briganti and Maria Matteini and Pasquale Ferri and Luca Vaggelli and Antonio Castagnoli and Cesco Pieroni},
  journal={Cancer biotherapy & radiopharmaceuticals},
  year={2001},
  volume={16 6},
  pages={515-24}
}
The study describes the results of Octreoscan SPET (OCTSPET) qualitative and semi-quantitative evaluation in 38 patients with suspected pancreatic neuroendocrine tumors. SPET studies were acquired at 4 and 24 hours after the injection of 111-220 MBq of 111-In-pentetreotide (Octreoscan). Qualitative and semi-quantitative evaluations were performed. The semi-quantitative approach was based on the time course of Tumor/Non Tumor ratios (TNTinc) from 4 and 24 hours. The OCTSPET results were true… CONTINUE READING
7 Citations
0 References
Similar Papers